Patients should have final say and control over their health data, HHS said Tuesday.
Trump administration officials Tuesday said they won’t be deterred by some industry opposition to their plan to move forward with rules to modernize patient data, make it portable, and create interoperability.
At the second day of the Academy Health combined National Health Policy Conference and Health Datapalooza, HHS Secretary Alex Azar and Don Rucker, the department’s national coordinator for health information technology in the Office of the National Coordinator for Health IT (ONC), said the issue of who should be in control of patient data is about access and choice.
The release of final interoperability and patient information access rules from Rucker’s office is expected shortly. The rules seek to end information blocking and give patients more control and choice over their data.
“Patients should be able to access their electronic medical record at no cost, period,” said Azar. “Providers should be able to use the IT tools that allow them to provide the best care for patients, without excessive costs or technical barriers.”
Last month, Epic, the nation’s largest provider of electronic health record (EHR) software, asked that the rules be delayed, saying that patient privacy is at stake.
“Unfortunately, defenders of the balkanized, outdated status quo have fought our proposals fiercely,” Azar said. “Scare tactics are not going to stop the reforms that we need.”
Following Azar’s appearance, Rucker was asked by Lisa Simpson, MB, BCh, MPH, president and chief executive officer of AcademyHealth, if he thought the privacy concerns are real.
Although privacy is a huge issue, he said, most people love the convenience of modern computing power contained in their smartphones. “I think when the rule comes out you’re going to see some pretty solid protections,” he said.
Regardless, he said, it's the patient who should have final say over their data—the rule does not mean that they have to do anything with it or take advantge of any options..
The issue of patient choice makes sense when one is not sick, Simpson said, but Rucker disagreed with that point.
"You can make healthcare decisions before you’re in extremis," he said.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More